Contact Information:

Media Contact

Margaret Allen
mallen@smu.edu
214-768-7664

Twitter: smu

http://www.smu.edu




Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.

PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery

New model allows pharmacological researchers to dock nearly any drug and see how it behaves in P-glycoprotein, a protein in the cell associated with failure of chemotherapy


Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery
2015-09-08
(Press-News.org) Drugs important in the battle against cancer responded the way they do in real life and behaved according to predictions when tested in a computer-generated model of one of the cell's key molecular pumps -- the protein P-glycoprotein, or P-gp.

Biologists at Southern Methodist University, Dallas, developed the computer generated model to overcome the problem of relying on only static images for the structure of P-gp, said biologist John G. Wise, lead author on the journal article announcing the advancement.

The new SMU model allows researchers to dock nearly any drug in the P-gp protein and see how it will actually behave in P-gp's pump, said Wise, an associate professor in SMU's Department of Biological Sciences.

"The value of this fundamental research is that it generates dynamic mechanisms that let us understand something in biochemistry, in biology," he said. "And by understanding P-gp in such detail, we can now think of ways to better and more specifically inhibit it."

P-gp is the cellular pump that protects cells by pumping out toxins. But that's a problem when P-gp targets chemotherapy drugs as toxic, preventing chemo from killing cancer cells. Scientists are searching for ways to inhibit P-gp's pumping action.

The SMU researchers tested Tariquidar, a new P-gp inhibitor still in clinical trials. Inhibitors offer hope for stopping P-gp's rejection of chemotherapeutics by stalling the protein's pumping action. Pharmacology researchers disagree, however, on where exactly Tariquidar binds in P-gp.

When run through the SMU model, Tariquidar behaved as expected: It wasn't effectively pumped from the cell and the researchers observed that it prefers to bind high in the protein.

"Now we have more details on how Tariquidar inhibits P-gp, where it inhibits and what it's actually binding to," Wise said.

Also using the model, the researchers discovered greater detail than previously known about the behavior of other drugs as well, and how those drugs bind in P-gp to stop its pumping action.

The study was funded in part by the National Institutes of Health. The lab was recently awarded a second NIH grant for the research.

The findings are published in the journal Biochemistry. The article, "Multiple drug transport pathways through human P-glycoprotein," is published online in advance of print at NIH's PubMed Central at http://bit.ly/1M2jexJ.

A still image of the modeled protein in action will appear on the cover of the October through December issues of Biochemistry.

Testing the virtual P-gp model by virtually docking real drugs Wise and his colleagues tested one of the workhorse drugs of chemotherapy, daunorubicin, a close cousin of Adriamycin. An aggressive chemotherapeutic, daunorubicin stops DNA replication in the cell, and is a classic target for P-gp to pump out of a cell, Wise said.

"For a long time, it's been thought that there are at least a couple of distinct binding sites for drugs," Wise said. "Sure enough, with our models, we found that daunorubicin, at least, prefers to bind on one side of the P-gp model, while verapamil - a commonly prescribed blood pressure medicine - prefers the other side."

Not only did the researchers show computationally that there are two different starting points for drugs, they also showed that there are two different pathways to get the drugs through.

"The two different drugs start at different sites and they're funneled to the outside by being pushed by the protein," Wise said. "But the actual parts of the protein that are pushing the drugs out are different."

Wise and his co-authors, SMU biologists Pia Vogel and James McCormick, created the P-gp computer-generated simulation using the massive processing capacity of SMU's High Performance Computer, ManeFrame.

Molecular model can aid in fight against multi-drug resistance of cancer cells The capability of watching molecular machinery up close, while doing its job the way it does in real life, may spark new drug discoveries to fight cancer, Wise said.

"Having an accurate model that actually moves - that shows the dynamics of the thing - is incredibly helpful in developing therapies against a molecular target to inhibit it. The only other ways to do it are blind, and the chances of success using blind methods are very low," Wise said.

"Scientists have tried for 30 years to find inhibitors of this pump and have done it without knowing the structure and with only little knowledge about the mechanism, screening more or less blindly for compounds that inhibit the thing," Wise said. "They found drugs that worked in the test tube and that worked in cultured cells, but that didn't work in the patient. With our model, because we can see the pump moving, we can probably predict better what's going to make an inhibitor actually work well."

Vogel and Wise led a team of researchers in using the P-gp model to virtually screen millions of publically available drug-like compounds. They discovered three new drug leads that could ultimately inhibit P-gp and offer better odds of survival to prostate cancer patients. The researchers reported the findings this month in the journal Pharmacology Research & Perspectives, http://bit.ly/1XGjN5w.

New SMU model simulates molecular machinery in action Researchers look for drug compounds that can temporarily stop or inhibit the P-gp pump, so that the chemotherapy drugs that enter the cancer cell will stay there and do the job of killing the cancer. Finding the right pump inhibitor requires understanding the pumping action. That's difficult without seeing the pump at work.

The structures of proteins similar to P-gp have been previously available in a static state through X-ray crystallography. Scientists use X-ray crystallography as a tool that essentially draws the details of biological structures by identifying their atomic and molecular structure through diffraction of X-rays by the atoms themselves.

Scientists often contribute the resulting protein structures to the U.S. Protein Data Bank repository for public use.

Detailed data combined with several trillion calculations produced model To build the P-gp model, Wise used structures from the repository, showing various stages of transport, to simulate four points of reference. From there, SMU's ManeFrame supercomputer was fed parameters and characteristics of the protein as well as how it should behave physically, including when kinetic energy was added to bring the protein and its surrounding membrane and water up to body temperature. The animated model resulted from calculating differences between two structures and using targeted molecular dynamics programs to slightly nudge the model to the next step.

"You do that several million times and make several trillion calculations and you arrive at the next structure," Wise said. "In this way, we can nudge P-gp through a full catalytic transport cycle."

Finally, using a docking program, the researchers individually introduced daunorubicin and other drugs into the protein, and watched the drugs move through P-gp's catalytic cycle.

"What happened was -- the drugs moved," Wise said. "And they moved the way they should move, clinically, biochemically, physiologically, to pump the compounds out of the cell."

Vogel added that, "in some of the zoom-ins of the model, you can actually see the amino acids paddle down the drugs."

Further challenging and testing the model The researchers ran a critical control to further test if the model worked.

"We thought maybe anything you put in the protein, relevant or not, would get pumped through. So we put in something that is not a transport substrate of P-gp, something that biochemically would never be transported by P-gp," Wise said. "We put it in, starting where daunorubicin is effectively pumped out, and very quickly the compound left the protein -- but it left the opposite way, back into the cell. This experiment gave us more confidence that what we are seeing in these models is reflecting what happens in the cell."

Wise admits that until he saw it for himself, even he had doubts the virtual P-gp model would behave like real-life P-gp.

"It's a crude approximation of a complex, sophisticated human protein, but it's so much better than the static images available now," Wise said. "I've got to emphasize for all the disbelievers, for the 'culture of doubters' out there, that this model works -- it moves the drugs through the membrane. That speaks for itself. What P-gp does in the cell, cancerous or normal, it does in our simulations."

INFORMATION:

SMUResearch.com on Twitter, http://twitter.com/smuresearch.

For more information, http://www.smuresearch.com.

SMU is a nationally ranked private university in Dallas founded 100 years ago. Today, SMU enrolls nearly 11,000 students who benefit from the academic opportunities and international reach of seven degree-granting schools. For more information see http://www.smu.edu.

SMU has an uplink facility located on campus for live TV, radio, or online interviews. To speak with an SMU expert or book an SMU guest in the studio, call SMU News & Communications at 214-768-7664.


[Attachments] See images for this press release:
Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery 2 Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery 3

ELSE PRESS RELEASES FROM THIS DATE:

As demand for African timber soars, birds pay the ultimate price

As demand for African timber soars, birds pay the ultimate price
2015-09-08
Tropical forests are home to more of the world's terrestrial biodiversity than any other habitat, but are increasingly threatened by the impact of human activities. Illegal logging, in particular, poses a severe and increasing threat to tropical forests worldwide. But, until now, its impact on tropical wildlife has not been quantified. A new study co-authored by scientists at Drexel University, published in the most recent issue of Biological Conservation, reveals the devastating impact of illegal logging on bird communities in the understory layer of Ghana's Upper Guinea ...

Arthritis may be a major driver of poverty

2015-09-08
Developing arthritis increases the risk of falling into poverty, especially for women, new research shows. In a study of more than 4,000 Australian adults, females who developed arthritis were 51% more likely to fall into income poverty than nonarthritic women. In men, arthritis was linked with a 22% increased risk. Also, women with arthritis were 87% more likely to fall into "multidimensional poverty," which includes income, health, and education attainment, while the arthritis-related risk in men was 29%. The investigators noted that given the high prevalence of ...

New findings shed light on fundamental process of DNA repair

2015-09-08
Inside the trillions of cells that make up the human body, things are rarely silent. Molecules are constantly being made, moved, and modified--and during these processes, mistakes are sometimes made. Strands of DNA, for instance, can break for any number of reasons, such as exposure to UV radiation, or mechanical stress on the chromosomes into which our genetic material is packaged. To make sure cells stay alive and multiply properly, the body relies on a number of mechanisms to fix such damage. Although researchers have been studying DNA repair for decades, much remains ...

Advanced treatment and prognosis data available for TNM classification

2015-09-08
DENVER, Colo. - The publication of the Eighth Edition of the Tumor, Node and Metastasis (TNM) Classification of Lung Cancer will provide physicians around the world access to new data to more precisely stage and treat cases of lung cancer. That data, collected by the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee and presented at the 16th World Conference on Lung Cancer (WCLC) in Denver on Tuesday, Sept. 8, 2015 at the Colorado Convention Center, will be published in 2016. In 1998, IASLC established its Lung Cancer ...

Study defines criteria for MET-driven lung cancer suitable for crizotinib treatment

2015-09-08
Many cancers include increased copies of the gene MET. But in which cases is MET driving the cancer and in which do these increased copies happen to "ride along" with other molecular abnormalities that are the true cause of the disease? The answer influences whether a tumor will respond to drugs that inhibit MET, like crizotinib. A University of Colorado Cancer Center study being presented today at the 16th World Conference on Lung Cancer in Denver, Colorado sheds light on the best method to determine the threshold at which MET amplification becomes clinically relevant. "Generally, ...

Flu vaccine reduces hospitalizations and deaths among nursing home residents

2015-09-08
When the influenza vaccine is well matched to the prevailing strains of flu in a given season, patients in nursing homes are significantly less likely to be hospitalized or to die of pneumonia and other influenza related causes. The finding comes from a study of more than 1 million Medicare fee-for-service long-stay nursing home residents. When the vaccine's match with A/H3N2--the influenza strain typically responsible for severe symptoms--was excellent (75%) during an A/H3N2 predominant season, there was an estimated 2.0% reduction in deaths and a 4.2% reduction in ...

Personalized medicine's success needs accurate classification of tumors

2015-09-08
DENVER, Colo. - If cancer patients are to receive optimal treatment, clinicians must have an accurate histologic classification of the tumor and know its genetic characteristics, said William D. Travis, M.D., attending thoracic pathologist, Department of Pathology, at Memorial Sloan Kettering Cancer Center in New York City. Dr. Travis made his remarks today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC). Dr. Travis said the pathology and oncology professions made a big step towards this goal ...

Study's findings could help expand the donor pool for liver transplantation

2015-09-08
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age. A new study of DCD liver transplantations conducted at the Cleveland Clinic from 2005 to 2014 found no significant correlation between donor age and organ ...

Many childhood brain tumor survivors experience seizures

2015-09-08
New research reveals that seizures are frequent in childhood brain tumor survivors. Among 298 children who were diagnosed with a brain tumor at least 2 years earlier and were followed for an average of 7.6 years, 24% of patients experienced seizures at the start of the study and 14% continued to experience them on an ongoing basis. Certain factors such as the type of tumor, its location, and the extent of surgery predispose patients to ongoing seizures. "This information will allow clinicians to understand better who needs to stay on antiseizure medications and who ...

Exposure to wildfire smoke linked to increased ER visits for asthma

2015-09-08
Researchers who analyzed data from the 2006-2007 wildfires in Australia found that exposure to wildfire smoke was linked to increased visits to hospital emergency departments for asthma. The findings reveal the adverse health impacts due to wildfire particulate pollution in communities. These fine particulates are harmful because they are easily inhaled and remain present deep in the lungs. "Given the increase in frequency and intensity of wildfires experienced worldwide in recent years, it's important to understand the impact of wildfire smoke exposure on acute health ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery
New model allows pharmacological researchers to dock nearly any drug and see how it behaves in P-glycoprotein, a protein in the cell associated with failure of chemotherapy
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.